accessiontherapeutics.com | Immuno-oncology

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: / # Optimization for Google Ads Bot User-agent: AdsBot-Google-Mobile User-agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/* # Block PetalBot User-agent: PetalBot Disallow: / Sitemap: https://www.accessiontherapeutics.com/sitemap.xml # Auto generated, go to SEO Tools > Robots.txt Editor to change

Meta Tags

Title	Immuno-oncology \| Accession
Description	making immuno-oncology therapeutics more targeted and potent than ever Accession Therapeutics Limited is developing novel immuno-oncology therapeutics – combining high specificity and potency to counter tumour
Keywords	N/A

Server Information

WebSite	accessiontherapeutics.com
Host IP	23.236.62.147
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

accessiontherapeutics.com Valuation

US$1,395,330

Last updated: 2023-05-17 03:16:52

accessiontherapeutics.com has Semrush global rank of 7,585,521. accessiontherapeutics.com has an estimated worth of US$ 1,395,330, based on its estimated Ads revenue. accessiontherapeutics.com receives approximately 161,000 unique visitors each day. Its web server is located in United States, with IP address 23.236.62.147. According to SiteAdvisor, accessiontherapeutics.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$1,395,330
Daily Ads Revenue	US$1,288
Monthly Ads Revenue	US$38,640
Yearly Ads Revenue	US$463,679
Daily Unique Visitors	10,734
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
accessiontherapeutics.com. 3600	A	accessiontherapeutics.com. 3600	IP: 23.236.62.147
accessiontherapeutics.com. 3600	NS	accessiontherapeutics.com. 3600	NS Record: ns73.domaincontrol.com.
accessiontherapeutics.com. 3600	NS	accessiontherapeutics.com. 3600	NS Record: ns74.domaincontrol.com.
accessiontherapeutics.com. 3600	MX	accessiontherapeutics.com. 3600	MX Record: 0 accessiontherapeutics-com.mail.protection.outlook.com.
accessiontherapeutics.com. 3600	TXT	accessiontherapeutics.com. 3600	TXT Record: apple-domain-verification=LpVxcAPZtoHm7Evo
accessiontherapeutics.com. 3600	TXT	accessiontherapeutics.com. 3600	TXT Record: v=verifydomain MS=3128328
accessiontherapeutics.com. 3600	TXT	accessiontherapeutics.com. 3600	TXT Record: v=spf1 include:spf.protection.outlook.com -all

HtmlToTextCheckTime:2023-05-17 03:16:52

top of page home pipeline trocept our team news and events careers making immuno-oncology therapeutics more targeted and potent than ever before With its stealth virus platform technology, Trocept , Accession Therapeutics is focused on treating some of the most intractable and widespread forms of cancer. Led by immuno-oncology pioneer Bent Jakobsen, PhD FMedSci, the company is accelerating a pipeline of highly differentiated products towards the clinic. Trocept has generated exceptionally encouraging preclinical data. Accession Therapeutics’ first drug candidate is expected to be IND stage by late 2023, followed by a pipeline of candidates engineered to make a step-change in cancer treatment. our pipeline our science our latest news How Trocept works - Home "Accession Therapeutics’ Trocept approach enables us to design novel highly targeted treatments with the potential to eradicate all cells in a tumour, regardless of diversity. This enormous increase in the ability to target tumours

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Thu, 03 Mar 2022 08:43:26 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.accessiontherapeutics.com/
strict-transport-security: max-age=3600
x-wix-request-id: 1646297006.19521629008212615300
Age: 0
Server-Timing: cache;desc=miss, varnish;desc=miss, dc;desc=42
X-Seen-By: jeslxIFvDH4ulYwNNi+3Muwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVisPSpdvxhEEQZ13gnr6W/r,m0j2EEknGIVUW/liY8BLLqymrWSBpMfJbY0ZWU2hO35/HubKAh1QhTB6OuUXtTGV,2d58ifebGbosy5xc+FRalsEJ+9g4eYoQf+nPXI11JUIskj66bjgbpY1T4piq92N3W9AkVWH9AHHhnNYBu0r+CQ==,2UNV7KOq4oGjA5+PKsX47FYFm2N83zrCt43G+JG3v74fbJaKSXYQ/lskq2jK6SGP,9ADrBGWMd7SJ6/J4kjOvbQeDRubRfFhy6xJQIgnBsUY=,qJS91GsscGZlb16v+8nwmH1NdCbwj/z1YpfXXAm33fUPUN6zYCeYUhP+LoeE7OiY,/j+AjfLiOiE0Vc9NsP8sK5MtQHxPxZkY6202kSwJShhA8Oj2OFRLYwZIvhva8IlL4cC/MEKhXa0TKd4LZUfYNg==
Cache-Control: no-cache
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Thu, 03 Mar 2022 08:43:26 GMT
content-type: text/html; charset=UTF-8
content-length: 404856
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
etag: W/"3d26578422f3f990b60f4b2cb3a4ddcd"
content-language: en-US
strict-transport-security: max-age=3600
age: 86897
set-cookie: ssr-caching=cache#desc=hit#varnish=hit#dc#desc=euw3; Max-Age=20; Expires=Wed, 02 Mar 2022 08:35:28 GMT
server-timing: cache;desc=hit, varnish;desc=hit, dc;desc=euw3
x-seen-by: sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVgrNPYqP3Y9aKHeFTmS5v2M,qquldgcFrj2n046g4RNSVJ4l+wVB4mQPiZOpNtmAaj8=,2d58ifebGbosy5xc+FRalpEpo0hOzi6/DGtaBrz88C6vFn0t/+KQ0nf81pY8pwRsjoe2GMQJ/MdiMK4Y/vI700z0MP9wGHHZ5IVNiVM6uH0=,2UNV7KOq4oGjA5+PKsX47ARSt+S4p3KgmtdD48b3UGRYgeUJqUXtid+86vZww+nL
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
x-wix-request-id: 1646297006.527238851242114938
x-content-type-options: nosniff
server: Pepyaka/1.19.10

accessiontherapeutics.com Whois Information

Domain Name: ACCESSIONTHERAPEUTICS.COM
Registry Domain ID: 2571432643_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2022-02-26T01:54:04Z
Creation Date: 2020-11-10T07:59:05Z
Registry Expiry Date: 2022-11-10T07:59:05Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS73.DOMAINCONTROL.COM
Name Server: NS74.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2022-03-03T09:10:53Z <<<

accessiontherapeutics.com valuation and analysis